TechCare’s Novokid “natural” head-lice treatment is poised to enter Europe after the US based development firm granted MWMedical the rights to distribute the product in the Netherlands.
Under the terms of the deal, Netherlands-based MWMedical has gained the distribution rights for Novokid in its domestic market “in consideration of minimum purchase commitments”.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?